Why the study?
Do beta blockers reduce mortality in patients following myocardial infarction?
Population
Patients following myocardial infarction
Comparison
Beta blockers vs Control/placebo
Design
Review
Authors
Loading...
Early post-MI beta-blocker data insufficient to confirm mortality benefit; leaves open need for larger definitive RCTs.
Do beta blockers reduce mortality in patients following myocardial infarction?
This historical review highlights that early trials of beta blockers for secondary prevention of MI did not demonstrate a statistically significant reduction in mortality by intention-to-treat analysis, emphasizing the need for larger, well-designed trials.
J R Hampton (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: